Straits Times Index
3,072.99 -11.71 (-0.38%) S&P 500
4,539.47 -11.11 (-0.24%) Dow
35,701.07 +270.65 (+0.76%) Nasdaq
14,131.67 -126.82 (-0.89%) Bitcoin USD
37,732.39 -108.52 (-0.29%) CMC Crypto 200
780.41 -3.23 (-0.41%)
Intuitive Surgical, Inc. (ISRG)
| Previous close | 310.76 |
| Open | 310.76 |
| Bid | 309.51 x 800 |
| Ask | 309.61 x 800 |
| Day's range | 304.70 - 311.99 |
| 52-week range | 222.65 - 358.07 |
| Volume | |
| Avg. volume | 1,870,103 |
| Market cap | 108.928B |
| Beta (5Y monthly) | 1.31 |
| PE ratio (TTM) | 72.63 |
| EPS (TTM) | 4.26 |
| Earnings date | 22 Jan 2024 - 26 Jan 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 329.19 |
ZacksIntuitive Surgical, Inc. (ISRG) Stock Moves -0.06%: What You Should Know
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $310.76, denoting a -0.06% change from the preceding trading day.
ZacksIs Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Motley FoolJohnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?
It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery. Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools. In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.
